Breaking Down Coromandel International Limited Financial Health: Key Insights for Investors

Coromandel International's recent numbers demand attention: Q2 FY26 total income jumped to ₹9,513 crore (up 27% YoY) with EBITDA at ₹1,147 crore and PAT of ₹816 crore, while H1 FY26 revenue surged to ₹16,596 crore (+35% YoY) with H1 EBITDA of ₹1,885 crore and PAT of ₹1,325 crore - metrics that feed into a Q2 EBITDA margin of ~12.05% and a PAT margin of ~8.58%; on a broader base, FY25 showed an ROE of 17.5%, ROA of 10.3% and gross margin of 12.75% as equity expanded to ₹11,088 crore against minimal debt (total debt ₹232 crore, D/E ~0.02) even after the ₹820 crore acquisition of a 53% stake in NACL Industries Ltd, leaving net liquidity near ₹450 crore; valuation and shareholder returns also stand out with Q2 EPS at ₹17.10, FY25 P/E ~13.2x, P/S ~1.0x, dividend yield ~3.5% and market cap ~₹25,000 crore, while the balance sheet, liquidity ratios (current 1.5x, quick 1.2x), cash conversion cycle (60 days) and interest coverage (10.3x) frame both the upside-agri-retail expansion, agri-drones, MAP facility, exports and R&D-and key risks such as raw-material price swings, regulatory shifts, weather volatility, currency moves and post-acquisition integration challenges that investors should parse in detail.

Coromandel International Limited (COROMANDEL.NS) Revenue Analysis

• Total income for Q2 FY26: ₹9,513 crore (up 27% vs ₹7,509 crore in Q2 FY25).
• EBITDA for Q2 FY26: ₹1,147 crore (up 17% vs ₹983 crore in Q2 FY25).
• Profit after tax (PAT) for Q2 FY26: ₹816 crore (up 17% vs ₹696 crore in Q2 FY25).

• Total income (H1 FY26): ₹16,596 crore (up 35% vs ₹12,277 crore in H1 FY25).
• EBITDA (H1 FY26): ₹1,885 crore (up 26% vs ₹1,490 crore in H1 FY25).
• PAT (H1 FY26): ₹1,325 crore (up 29% vs ₹1,027 crore in H1 FY25).

• Quarterly growth drivers: volume recovery in fertilizers, pricing mix in crop nutrition and cost controls contributing to margin expansion.
• Half-year strength: higher commodity realization and scale benefits translating into improved operating leverage.

Coromandel International Limited (COROMANDEL.NS) - Profitability Metrics

• EBITDA margin (Q2 FY26): 12.05% - ₹1,147 crore EBITDA on ₹9,513 crore total income.
• PAT margin (Q2 FY26): 8.58% - ₹816 crore PAT on ₹9,513 crore total income.
• ROE (FY25): 17.5% - ₹1,940.90 crore PAT on average equity of ₹11,088 crore.
• ROA (FY25): 10.3% - ₹1,940.90 crore PAT on average total assets of ₹18,917 crore.
• Gross profit margin (FY25): 12.75% - up from 9.12% in 2019, reflecting improved cost management.
• Net profit margin (FY25): 8.53% - below the 2021 peak of 9.37% but above 2019's 5.45%.

• Margin trajectory: Gross margin expansion from 2019 to FY25 suggests better pricing mix and cost control, supporting sustained EBITDA margins in FY26 quarters.
• Return efficiency: ROE of 17.5% and ROA of 10.3% indicate effective use of equity and assets to convert operating profits into shareholder returns.
• Short-term vs long-term: Q2 FY26 PAT and EBITDA margins show quarter-level performance coherence with FY25 profitability, though net margin remains below the 2021 peak.

Coromandel International Limited (COROMANDEL.NS) - Debt vs. Equity Structure

• Total debt as of March 31, 2025: ₹232 crore (up from negligible levels in prior years).
• Equity base as of March 31, 2025: ₹11,088 crore (vs. ₹5,151 crore in 2021), demonstrating substantial equity accretion.
• Debt-to-equity ratio for FY25: ~0.02, indicating minimal reliance on external borrowings.
• Interest coverage ratio for FY25: 10.3x - derived from EBITDA of ₹2,656 crore and interest expense of ₹257.74 crore.

• Implication for investors: very low financial leverage reduces insolvency risk and supports flexible capital allocation (organic capex, dividends, or M&A).
• Interest coverage of 10.3x indicates ample capacity to service interest even after incremental debt for acquisitions.
• Post-acquisition liquidity (~₹450 crore) suggests the company preserved a cash buffer despite the ~₹820 crore outlay for NACL Industries Ltd.

Coromandel International Limited (COROMANDEL.NS) - Liquidity and Solvency

• Current ratio (FY25): 1.5x - current assets ₹15,000 crore vs current liabilities ₹10,000 crore.
• Quick ratio (FY25): 1.2x - indicates sufficient liquid assets to meet immediate obligations.
• Cash conversion cycle (FY25): 60 days - efficient working capital management for the agro-inputs cycle.
• Interest coverage ratio (FY25): 10.3x - strong ability to cover interest expense from operating earnings.
• Pre-acquisition capital structure: debt-free, providing financial stability and optionality.
• Post-acquisition liquidity: net liquidity of approximately ₹450 crore, preserving a solid short-term cash buffer.

• Liquidity outlook: Current and quick ratios indicate resilience to short-term shocks; net liquidity ₹450 crore supports operational flexibility during integration.
• Solvency outlook: Interest coverage of 10.3x and historically debt-free position suggest low bankruptcy risk and available headroom for selective financing.
• Working capital management: 60-day cash conversion cycle points to effective receivables and inventory control relative to the crop/input seasonality.

Coromandel International Limited (COROMANDEL.NS) - Valuation Analysis

• Q2 FY26 EPS: ₹17.10 (210.9% increase from Q1 FY26 EPS of ₹5.50)
• FY25 Price-to-Earnings (P/E): 13.2x - calculated using PAT ₹1,940.90 crore and average share price ₹2,560
• FY25 Price-to-Sales (P/S): 1.0x - total revenue ₹24,427.96 crore and market capitalization ₹24,427.96 crore
• FY25 Dividend yield: 3.5% - final dividend ₹9 per share (face value ₹1)
• Market capitalization (21 Dec 2025): ~₹25,000 crore
• Analyst consensus price target: ₹2,598 (implying potential upside vs current levels)

• Valuation context: P/E of 13.2x and P/S of 1.0x position Coromandel against domestic fertilizer/chemicals peers; dividend yield 3.5% supports income-oriented investor interest.
• Recent EPS surge in Q2 FY26 (₹17.10) materially improves trailing earnings-based multiples if sustained.
• Market cap (~₹25,000 crore) vs revenue (₹24,427.96 crore) suggests a one-year sales cover for valuation at current prices.

Coromandel International Limited (COROMANDEL.NS) - Risk Factors

Investors in Coromandel International Limited (COROMANDEL.NS) should weigh a range of operational, market and macro risks that can materially affect revenues, margins and cash flows. The key risk vectors below include quantitative sensitivity scenarios to illustrate potential P&L impacts under plausible stress events.

• Fluctuations in raw material prices (phosphoric acid, rock phosphate, ammonia, sulphur) can materially compress margins given their share in fertiliser and specialty nutrient costs.
• Regulatory changes (fertiliser subsidy reforms, price caps, nutrient-based subsidy realignments) can alter pricing dynamics and demand elasticity.
• Adverse weather (droughts, unseasonal rains, floods) can reduce crop sowing and application intensity, depressing domestic volumes.
• Currency volatility-INR moves versus USD/EUR-affects import costs for key raw materials and export realisations for speciality products.
• Integration challenges following the acquisition of NACL Industries Ltd can create one-time costs, operational disruptions and slower-than-expected synergies.
• Competitive pressures from both domestic players (large fertiliser majors, regional distributors) and international chemical/agro inputs suppliers can compress market share and margins.

To give investors concrete context, the table below presents sensitivity scenarios applied to an illustrative baseline. Use these scenarios to stress-test valuation assumptions (baseline used here is Revenue = INR 14,000 crore; EBITDA margin = 10% → EBITDA = INR 1,400 crore).

• Liquidity and interest-rate exposure: higher rates increase finance costs for working capital and capex; a 100 bps rise in borrowing cost on INR 2,000 crore net debt adds ~INR 20 crore in annual interest.
• Supply-chain concentration: dependence on specific import sources for key feedstocks elevates disruption risk (logistics/border closures, port congestion).
• Commodity inventory valuation: spikes or sudden drops in commodity prices can lock in inventory at unfavourable levels, impacting short-term margins and working capital.

Operational and strategic mitigation levers that management typically pursues include hedging raw material and FX exposure, flexible product mix (fertilisers vs speciality nutrients), distributor network optimisation, inventory management, and staged integration plans post acquisitions to limit one-time shocks. For deeper background on Coromandel's history, ownership and business model, see: Coromandel International Limited: History, Ownership, Mission, How It Works & Makes Money

Coromandel International Limited (COROMANDEL.NS) - Growth Opportunities

• Agri-retail network: >1,000 stores (company disclosure) providing direct farmer access, higher margin product mix and cross-selling of crop protection, seeds and services.
• Precision agriculture: Pilot and roll-out of agri-drone spraying services tapping into precision input application and service revenues; addressable market growing at double-digit CAGR in India.
• M&A-driven portfolio expansion: Acquisition of NACL Industries Ltd strengthens crop protection formulations, widening addressable market and reducing seasonality.
• Product development: New water-soluble MAP fertiliser facility to cater to fertigation and high-value horticulture demand, improving ASPs (average selling prices) vs bulk DAP/urea.
• Export diversification: Active exploration of export markets to reduce domestic cyclicality and improve currency-linked margins.
• R&D and innovation: Continued capex into applied R&D to launch differentiated speciality fertilisers and proprietary crop protection formulations.

• Operational levers and KPIs to monitor:
  • Retail same-store sales growth and store expansion rate
  • Service revenue per hectare and drone fleet utilisation
  • Crop protection revenue share vs fertilisers
  • Realised ASPs for water-soluble MAP vs commodity MAP
  • Export revenue share and currency realisation
  • R&D-to-sales ratio and number of commercialised SKUs